CompoAtlas

Baume de l'Ours

Natural health product licensed in Canada

Licence holder
Veevance Inc.
NPN or DIN-HM
80021238
Status
Inactive licence
Licence date
12 August 2010
Revision date
6 July 2021
Form
Crème
Route of administration
Topique
Application type
TPD Cat IV/LS

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Menthol

Source : Menthol

2.5 %

Non-medicinal ingredients

Paraffine, Gelée de pétrole blanche

PopulationAgeQuantity per servingFrequency
Enfantsminimum: 2 years1 Applicatorminimum: 3 Tous les jours ; maximum: 4 Tous les jours
AdultesNot specified1 Applicatorminimum: 3 Tous les jours ; maximum: 4 Tous les jours

Uses authorised in Canada

Pour le soulagement temporaire des maux et douleurs des muscles et articulations associés aux maux de dos, lumbago, efforts, contusions, entorses, foulures douleurs arthritiques et rhumatismales, douleurs des tendons et des ligaments. Pour les muscles fatigués et endoloris.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80021238

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2021. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line